Myriad Genetics MYGN Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's accounts payable?
- Myriad Genetics (MYGN) reported accounts payable of $32.6M in Q1 2026.
- How has Myriad Genetics's accounts payable changed year-over-year?
- Myriad Genetics's accounts payable increased by 16.0% year-over-year, from $28.1M to $32.6M.
- What is the long-term trend for Myriad Genetics's accounts payable?
- Over 5 years (2020 to 2025), Myriad Genetics's accounts payable has grown at a 7.9% compound annual growth rate (CAGR), from $20.5M to $30M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.